4Schalm SW, Heat heote J , Cianiara J , et al . Lamivudine and alpha intederon combination treatment of patients with chronic hepatitis B in- fection:a randomised trial[J] .Gut,2000,46(4):562. 被引量：1
8$wanston WH. Methicillin resistant Staphylococcus aureus[J]. West In- dia Med J, 1999,48(1) :20. 被引量：1
9Fridkin SK, Lawton R, Edwards JR, et al. Monitoring antimicrobial use and resistance', oomparison with a national benchmark on reducing van- eomyoin use and vancomyoin-resistant enterococci[J]. Emerg Infect Dis, 2002,8(7) :702. 被引量：1
8World Health Organization.WHO global strategy for containment of antimicrobial resistance[EB/ OL].WHO/ CDS/ CSR/DRS/ 2001.2. 被引量：1
9Clinical and Laboratory Standards Institute (CLSI/NCCLS).Performance Standards for Antimicrobial Susceptibility Testing;Fifteenth Informational Supplement[S].2009,M100-S19. 被引量：1
10Paterson DL.The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species[J].Clin Infect Dis,2006,43 (Suppl 2):S43-S48. 被引量：1
